Trump Says U.S. to Provide GLP-1 Drugs for Medicare Patients
THE VILLAGES, Florida, May 1 (Reuters) – U.S. President Donald Trump said on Friday the government is moving to make GLP-1 weight-loss and diabetes drugs available to seniors enrolled in Medicare from July 1. (Reporting By Jarrett Renshaw; editing by Michelle Nichols ) Copyright 2026 Thomson Reuters.